Pulse Biosciences Board Unanimously Approves Plan To Initiate Rights Offering Of Up To $60M Worth Of Units

Pulse Biosciences, Inc. -4.77%

Pulse Biosciences, Inc.

PLSE

13.37

-4.77%

Robert Duggan, the Company's Executive Chairman and majority stockholder, has indicated his support for the rights offering and his intent to participate in the rights offering on the same terms as all other investors.

Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via